Eurofins-Cerep SA (EPA:ALECR)
France
· Delayed Price · Currency is EUR 20,600
0.00 (0.00%)
Jan 29, 2025, 4:30 PM CET
Eurofins-Cerep Revenue
In the year 2024, Eurofins-Cerep had annual revenue of 40.49M EUR, down -8.13%. Eurofins-Cerep had revenue of 20.60M in the half year ending December 31, 2024, a decrease of -16.40%.
Revenue
40.49M
Revenue Growth
-8.13%
P/S Ratio
2.57
Revenue / Employee
195.59K
Employees
207
Market Cap
103.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.49M | -3.58M | -8.13% |
| Dec 31, 2023 | 44.07M | -3.58M | -7.51% |
| Dec 31, 2022 | 47.65M | 6.01M | 14.45% |
| Dec 31, 2021 | 41.63M | 8.97M | 27.45% |
| Dec 31, 2020 | 32.67M | 1.66M | 5.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |